PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2015

Sep 10, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2015-09-08

Reporting Person: WILSON TROY EDWARD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-08	Stock Option (Right to Buy)	$95.22	A	10000	Acquired	2025-09-07	Common Stock (10000)	Direct

Footnotes

F1: The vesting commencement date ("VCD") of the option is September 8, 2015. The option vests (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the VCD, and (ii) with respect to an additional 1/36th of the shares subject thereto on each monthly anniversary of the VCD thereafter, subject to the Reporting Person's continued service on the Nominating and Corporate Governance Committee of the Board of Directors of the Issuer through each vesting date.